• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCOPA睡眠量表和帕金森病睡眠量表:两种评估帕金森病睡眠障碍的量表。

SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.

作者信息

Martinez-Martin Pablo, Visser Martine, Rodriguez-Blazquez Carmen, Marinus Johan, Chaudhuri K Ray, van Hilten Jacobus J

机构信息

National Centre of Epidemiology, Carlos III Institute of Health, Madrid, Spain.

出版信息

Mov Disord. 2008 Sep 15;23(12):1681-8. doi: 10.1002/mds.22110.

DOI:10.1002/mds.22110
PMID:18709672
Abstract

This study evaluated the comparative validity and usefulness of the Parkinson's Disease Sleep Scale (PDSS) and the Scales for Outcomes in PD-Sleep Scale (SCOPA-S), two disease-specific rating scales for assessing sleep disorders in Parkinson's disease (PD). Hoehn and Yahr staging (HY), SCOPA-Motor, Mini-Mental State Examination, Clinical Impression of Severity Index for PD, Hospital Anxiety and Depression Scale, EuroQoL, and SCOPA-Psychosocial, in addition to PDSS and SCOPA-S (night-time sleep (NS) and daytime sleepiness (DS) subscales), were applied to 187 consecutive PD patients. PDSS and SCOPA-S proved similar in acceptability, scaling assumptions, precision, and internal consistency (Cronbach's alpha = 0.82-0.84). Factor analysis revealed five separate factors for PDSS (67% of the variance) and one factor for each SCOPA-S subscale (60% of the variance for NS and 57% for DS). Correlation coefficient between PDSS and SCOPA-S NS was -0.60. Sleep scales correlated moderately with mood, low-to-moderate with HRQoL, and low with the rest of measures. PDSS and SCOPA-S DS discriminated between patients grouped by HY severity levels and disease duration. Cutoff points of 82/83 for PDSS and 6/7 for SCOPA-S NS were drawn to identify PD patients with sleep problems. Depression/anxiety scores explained 26% for PDSS and 22% for SCOPA-S NS scores. Both scales provide valid, reliable, and useful means to evaluate sleep disorders in PD. PDSS may be used to obtain a profile about potential causes of "bad sleep," but is barely useful to assess DS, whereas SCOPA-S assesses nocturnal sleep disorders and daytime somnolence at a similar extent, without exploring the potential causes.

摘要

本研究评估了帕金森病睡眠量表(PDSS)和帕金森病睡眠结局量表(SCOPA-S)这两种用于评估帕金森病(PD)睡眠障碍的疾病特异性评定量表的比较效度和实用性。除了PDSS和SCOPA-S(夜间睡眠(NS)和日间嗜睡(DS)子量表)外,还对187例连续的PD患者应用了霍恩和雅尔分期(HY)、SCOPA-运动量表、简易精神状态检查表、PD严重程度临床印象指数、医院焦虑抑郁量表、欧洲生活质量量表以及SCOPA-心理社会量表。PDSS和SCOPA-S在可接受性、量表假设、精确性和内部一致性方面(克朗巴哈系数=0.82 - 0.84)相似。因子分析显示PDSS有五个独立因子(占方差的67%),SCOPA-S每个子量表有一个因子(NS占方差的60%,DS占方差的57%)。PDSS与SCOPA-S NS的相关系数为-0.60。睡眠量表与情绪呈中度相关,与健康相关生活质量呈低至中度相关,与其他测量指标呈低度相关。PDSS和SCOPA-S DS能够区分按HY严重程度水平和病程分组的患者。得出PDSS的截断点为82/83,SCOPA-S NS的截断点为6/7,以识别有睡眠问题的PD患者。抑郁/焦虑评分对PDSS得分的解释率为26%,对SCOPA-S NS得分的解释率为22%。两种量表都为评估PD中的睡眠障碍提供了有效、可靠且有用的方法。PDSS可用于获取有关“睡眠不佳”潜在原因的概况,但几乎无法用于评估DS,而SCOPA-S在相似程度上评估夜间睡眠障碍和日间嗜睡情况,且不探究潜在原因。

相似文献

1
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.SCOPA睡眠量表和帕金森病睡眠量表:两种评估帕金森病睡眠障碍的量表。
Mov Disord. 2008 Sep 15;23(12):1681-8. doi: 10.1002/mds.22110.
2
[A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep].帕金森病睡眠障碍特定测量方法的一项试点研究:SCOPA-睡眠量表
Rev Neurol. 2006;43(10):577-83.
3
[Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].[帕金森病心理社会结局量表(SCOPA-PS)的心理测量属性:西班牙的验证及综述]
Rev Neurol. 2009;49(1):1-7.
4
Psychometric attributes of the SCOPA-COG Brazilian version.SCOPA-COG巴西版本的心理测量学属性。
Mov Disord. 2008 Jan;23(1):81-7. doi: 10.1002/mds.21769.
5
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.帕金森病非运动症状量表心理测量属性的国际研究。
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.
6
Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version.帕金森病睡眠量表巴西版的心理测量学特性。
Parkinsonism Relat Disord. 2009 Aug;15(7):495-9. doi: 10.1016/j.parkreldis.2008.12.008. Epub 2009 Feb 10.
7
The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.未经治疗的帕金森病(PD)睡眠功能障碍的范围和性质。一项使用帕金森病睡眠量表和选择性多导睡眠图的对照临床研究。
J Neurol Sci. 2006 Oct 25;248(1-2):158-62. doi: 10.1016/j.jns.2006.05.004. Epub 2006 Jun 15.
8
The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.帕金森病严重程度指数的临床印象:国际验证研究。
Mov Disord. 2009 Jan 30;24(2):211-7. doi: 10.1002/mds.22320.
9
Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale.中国帕金森病患者的睡眠障碍:帕金森病睡眠量表中文版的验证研究
J Neurol Sci. 2008 Aug 15;271(1-2):153-7. doi: 10.1016/j.jns.2008.04.008. Epub 2008 May 27.
10
[Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].[帕金森病认知评定量表的心理测量学属性。一项独立验证研究]
Rev Neurol. 2009;49(8):393-8.

引用本文的文献

1
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.帕金森病自主神经功能衰竭、疼痛及睡眠障碍的诊断与治疗:德国神经病学学会“帕金森病”指南
J Neurol. 2025 Jan 3;272(1):90. doi: 10.1007/s00415-024-12730-5.
2
Deep cervical lymph nodes in Parkinson's disease and atypical Parkinson's disease: A potential ultrasound biomarker for differential diagnosis.帕金森病和非典型帕金森病中的颈深淋巴结:一种用于鉴别诊断的潜在超声生物标志物。
J Cent Nerv Syst Dis. 2024 Jul 29;16:11795735241259429. doi: 10.1177/11795735241259429. eCollection 2024.
3
Gray matter volume alterations in de novo Parkinson's disease: A mediational role in the interplay between sleep quality and anxiety.
首发帕金森病患者脑灰质体积改变:睡眠质量与焦虑相互作用的中介作用
CNS Neurosci Ther. 2024 Jul;30(7):e14867. doi: 10.1111/cns.14867.
4
A diagnostic model for Parkinson's disease based on circadian rhythm-related genes.基于昼夜节律相关基因的帕金森病诊断模型。
J Transl Med. 2024 Jul 8;22(1):635. doi: 10.1186/s12967-024-05424-z.
5
Parkinson's Kinetigraph for Wearable Sensor Detection of Clinically Unrecognized Early-Morning Akinesia in Parkinson's Disease: A Case Report-Based Observation.帕金森病可穿戴传感器检测临床无识别的清晨运动不能症的 Kinetigraph:基于病例报告的观察。
Sensors (Basel). 2024 May 11;24(10):3045. doi: 10.3390/s24103045.
6
Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.帕金森病患者的健康相关生活质量:EuroQol (EQ-5D) 效用评分的系统评价和荟萃分析。
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
7
Neurological Insights into Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的神经学见解
Brain Sci. 2023 Aug 14;13(8):1202. doi: 10.3390/brainsci13081202.
8
Effectiveness of Neurofunctional Physical Therapy on the Quality of Sleep of Individuals with Parkinson's Disease: Case Series.神经功能物理治疗对帕金森病患者睡眠质量的有效性:病例系列
Sleep Sci. 2023 Jul 6;16(2):206-215. doi: 10.1055/s-0043-1770801. eCollection 2023 Jun.
9
Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease.空肠内左旋多巴输注对晚期帕金森病患者睡眠的长期影响。
Front Neurol. 2023 Apr 20;14:1105650. doi: 10.3389/fneur.2023.1105650. eCollection 2023.
10
Australian Parkinson's Genetics Study (APGS): pilot (n=1532).澳大利亚帕金森遗传学研究(APGS):先导研究(n=1532)。
BMJ Open. 2022 Feb 25;12(2):e052032. doi: 10.1136/bmjopen-2021-052032.